FINWIRES · TerminalLIVE
FINWIRES

調査速報:Bldpは第1四半期の業績がまちまちだったものの、利益率は改善した。

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。BLDPの2026年第1四半期決算は、売上高が前年同期比26%増の1,940万ドルとなり、市場予想を83万ドル下回りましたが、GAAPベースの1株当たり利益(EPS)はマイナス0.04ドルで、市場予想を0.02ドル上回りました。成長を支えたのは、鉄道事業の売上高が前年同期の10万ドルから510万ドルに急増したことと、定置型発電事業が前年同期の60万ドルから520万ドルに増加したことでした。一方、バス事業の売上高は46%減の680万ドルとなり、市場の継続的な課題を反映しています。最も注目すべき改善点は、粗利益率が2025年第1四半期のマイナス23%から14%にプラスに転じたことです。これは、2024年から2025年にかけて実施されたコスト削減策とグローバルな事業再編プログラムによる640万ドルの改善を反映しています。経営陣は、2026年の営業費用を6,500万ドル~7,500万ドル、設備投資を500万ドル~1,000万ドルと予測しており、継続的なコスト管理を示しています。営業キャッシュフローが2,440万ドルから780万ドルへと大幅に改善し、営業費用が前年比37%減少したことから、業務改善を高く評価しています。同社は5億1,680万ドルの現金を保有し、潤沢な流動性を維持しています。また、受注残高は1億1,290万ドル、12ヶ月間の受注残高は5,280万ドルとなっており、収益の見通しが良好です。

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE